Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

A MEPS-UHPLC-MS/MS analytical platform to detect isoprostanoids and specialized pro-resolving mediators in the urinary extracellular vesicles of mountain ultramarathon runners

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Contributors:
      University of Pisa Italy = Università di Pisa Italia = Université de Pise Italie (UniPi); Institute of Clinical Physiology (IFC); National Research Council of Italy; University G. d'Annunzio Chieti; Università degli studi "G. d'Annunzio" Chieti-Pescara Chieti-Pescara (Ud'A); Department of Neurology and Neurophysiology; Mountain Medicine Center, Valle d’Aosta Regional Hospital; Institut des Biomolécules Max Mousseron Pôle Chimie Balard (IBMM); Institut de Chimie - CNRS Chimie (INC-CNRS)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM); Université de Montpellier (UM); Institutional funds from the University of Pisa supported the study.
    • Publication Information:
      CCSD
      Elsevier
    • Publication Date:
      2024
    • Collection:
      Université de Montpellier: HAL
    • Abstract:
      International audience ; Oxylipins are powerful signalling compounds derived from polyunsaturated fatty acids (PUFAs) and involved in regulating the immune system response. A mass spectrometry-based method was developed and validated for the targeted profiling of 52 oxylipins (e.g., isoprostanoids, prostaglandins, epoxy- and hydroxy-fatty acids, specialized pro-resolving mediators) and 4 PUFAs in small urinary extracellular vesicles (uEVs). Ultrasound-assisted extraction using a 50:50 v/v MeOH:H2O mixture ensured optimal analytical performances. Limits of detection ranged between 10 and 400 pg/mL for oxylipins and 0.10-3 ng/mL for PUFAs. Satisfactory recoveries (85-116 %) and good intra- and inter-day precisions (RSD ≤15 %) were obtained for all the analytes. The reliability of the procedure was tested in a real case scenario by monitoring ultramarathon runners during the world Tor des Géants® (TDG) race. Both F2- and E2-isoprostanes were detected in small uEVs of the ultramarathon runners, suggesting the onset of an oxidant insult. 5-F2t-IsoP exhibited significant pre- to post-race variations, thus potentially representing a non-invasive marker of in-vivo lipid peroxidation. The presence of specialized pro-resolving mediators suggests the activation of pro-resolution signalling cascade resolving inflammation. These outcomes may help manage post-exercise recovery and improve training.
    • Relation:
      info:eu-repo/semantics/altIdentifier/pmid/39067203; PUBMED: 39067203
    • Accession Number:
      10.1016/j.talanta.2024.126619
    • Online Access:
      https://hal.umontpellier.fr/hal-04729483
      https://hal.umontpellier.fr/hal-04729483v1/document
      https://hal.umontpellier.fr/hal-04729483v1/file/Manuscript_Biagini%20et%20alV2.pdf
      https://doi.org/10.1016/j.talanta.2024.126619
    • Rights:
      info:eu-repo/semantics/OpenAccess
    • Accession Number:
      edsbas.30E17435